Youbo Pharmaceutical

Harbin Youbo Pharmaceutical is a leading Chinese pharmaceutical company focused on the development and production of treatments for cardiovascular and cerebrovascular diseases. Founded in 1995 and headquartered in Harbin, the company is a major subsidiary of Jiuzhitang, following a significant restructuring in 2015. Its flagship product, Shuxuening Injection, is a standardized Ginkgo biloba extract that has become a market leader in China for treating ischemic conditions. Youbo integrates modern pharmacological research with traditional Chinese medicine principles, operating large-scale GMP-certified manufacturing facilities. The company's portfolio also includes products like Lumbrokinase capsules and various chemical drug formulations targeting chronic vascular health.